The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Projecting the Number of Patients with End-Stage Renal Disease in the United States to the Year 2015
Abstract
The size of the prevalent ESRD population in the United States increased dramatically during the 1990s, from 196,000 in 1991 to 382,000 in 2000. Incidence also increased considerably during the same period, from 53,000 to 93,000 per year. If previous trends in ESRD incidence and prevalence continue, then current levels of health care resources that are devoted to the care of these patients will eventually be unable to meet the demand. This study discusses a Markov model developed to predict ESRD incidence, prevalence, and mortality to the year 2015 and incorporating expected changes in age/race distributions, diabetes prevalence, ESRD incidence, and probability of death. The model predicted that by 2015 there will be 136,166 incident ESRD patients per year (lower/upper limits 110,989 to 164,550), 712,290 prevalent patients (595,046 to 842,761), and 107,760 ESRD deaths annually (96,068 to 118,220). Incidence and prevalence counts are expected to increase by 44 and 85%, respectively, from 2000 to 2015 and incidence and prevalence rates per million population by 32 and 70%, respectively. The financial and human resources that will be needed to care for these patients in 2015 will be considerably greater than in 2005.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Self-citationPrevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
The Continuing Epidemics of Obesity and Diabetes in the United States
Mokdad, A. H. (2001) · JAMA · doi:10.1001/jama.286.10.1195 · Cited by 2,730
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Diabetes trends in the U.S.: 1990-1998.
Mokdad, A. H., Ford, E. S., Bowman, B. A., Nelson, D. E., Engelgau, M. M., Vinicor, F., & Marks, J. S. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1278 · Cited by 1,042
The Public Health Impact of Obesity
Visscher, T. L., & Seidell, J. C. (2001) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.22.1.355 · Cited by 1,008
Projection of Diabetes Burden Through 2050
Boyle, J. P., Honeycutt, A. A., Narayan, K. M. V., Hoerger, T. J., Geiss, L. S., Chen, H., & Thompson, T. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1936 · Cited by 1,004
Skyler, J. S., & Oddo, C. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.289 · Cited by 359
Rh, G., Svendsen, K. H., Kasiske, B. L., Keane, W. F., & Mm, W. (1997) · PubMed · Cited by 169
Simulation model of renal replacement therapy: predicting future demand in England
Roderick, P. J., Davies, R., Jones, C., Feest, T., Smith, S. H., & Farrington, K. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg591 · Cited by 113
Cited by
Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768
Body Mass Index and Risk for End-Stage Renal Disease
Hsu, C.-Y., McCulloch, C. E., Iribarren, C., Darbinian, J., & Go, A. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00006 · Cited by 1,390
Prevalence of chronic kidney disease in population-based studies: Systematic review
Zhang, Q.-L., & Rothenbacher, D. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-117 · Cited by 1,021
Chronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000
Coresh, J., Byrd-Holt, D., Astor, B. C., Briggs, J. P., Eggers, P. W., Lacher, D. A., & Hostetter, T. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070539 · Cited by 842
Musso, G., Gambino, R., Tabibian, J. H., Ekstedt, M., Kechagias, S., Hamaguchi, M., Hultcrantz, R., Hagström, H., Yoon, S. K., Charatcharoenwitthaya, P., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001680 · Cited by 720
Cognitive impairment in hemodialysis patients is common
Murray, A. M., Tupper, D. E., Knopman, D. S., Gilbertson, D. T., Pederson, S. L., Li, S., Smith, G. E., Hochhalter, A. K., Collins, A. J., & Kane, R. L. (2006) · Neurology · doi:10.1212/01.wnl.0000225182.15532.40 · Cited by 712
Self-citationAssociation between obesity and kidney disease: A systematic review and meta-analysis
Wang, Y., Chen, X., Song, Y., Caballero, B., & Cheskin, L. J. (2008) · Kidney International · doi:10.1038/sj.ki.5002586 · Cited by 687
Prevalence of Kidney Damage in Australian Adults: The AusDiab Kidney Study
Chadban, S. J., Briganti, E. M., Kerr, P. G., Dunstan, D. W., Welborn, T. A., Zimmet, P. Z., & Atkins, R. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070152.11927.4a · Cited by 683
Kramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618
Schalkwijk, C. G., & Stehouwer, C. D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 622
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
Remuzzi, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27699 · Cited by 618
Extrahepatic complications of nonalcoholic fatty liver disease
Armstrong, M. J., Adams, L. A., Canbay, A., & Syn, W.-K. (2014) · Hepatology · doi:10.1002/hep.26717 · Cited by 600
Risk Factors for End-Stage Renal Disease: 25-Year Follow-up
Hsu, C.-Y., Iribarren, C., McCulloch, C. E., Darbinian, J., & Go, A. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.605 · Cited by 589
Haroun, M. K., Jaar, B. G., Hoffman, S. C., Comstock, G. W., Klag, M. J., & Coresh, J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000095249.99803.85 · Cited by 532
Bakris, G. L., Sarafidis, P. A., Weir, M. R., Dahlöf, B., Pitt, B., Jamerson, K., Velazquez, E. J., Staikos-Byrne, L., Kelly, R. Y., Shi, V., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62100-0 · Cited by 523
Inflammation and Progression of CKD: The CRIC Study
Amdur, R. L., Feldman, H. I., Gupta, J., Yang, W., Kanetsky, P., Shlipak, M., Rahman, M., Lash, J. P., Townsend, R. R., Ojo, A., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13121215 · Cited by 452
Chronic renal diseases as a public health problem: Epidemiology, social, and economic implications
Schieppati, A., & Remuzzi, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09801.x · Cited by 447
Hsu, C.-Y., Lin, F., Vittinghoff, E., & Shlipak, M. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000091586.46532.b4 · Cited by 432
Relationship between Moderate to Severe Kidney Disease and Hip Fracture in the United States
Nickolas, T. L., McMahon, D. J., & Shane, E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111194 · Cited by 412
Operations Research in Healthcare: a survey
Rais, A., & Viana, A. (2011) · International Transactions in Operational Research · doi:10.1111/j.1475-3995.2010.00767.x · Cited by 393
NOGUEIRA, A., PIRES, M. J., & OLIVEIRA, P. A. (2017) · In Vivo · doi:10.21873/invivo.11019 · Cited by 382
Renal Denervation in Moderate to Severe CKD
Hering, D., Mahfoud, F., Walton, A. S., Krum, H., Lambert, G. W., Lambert, E. A., Sobotka, P. A., Böhm, M., Cremers, B., Esler, M. D., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011111062 · Cited by 361
Projecting ESRD incidence and prevalence in the United States through 2030
McCullough, K. P., Morgenstern, H., Saran, R., Herman, W. H., & Robinson, B. M. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018050531 · Cited by 353
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
Calcutt, N. A., Cooper, M. E., Kern, T. S., & Schmidt, A. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2476 · Cited by 352
Watanabe, H., Watanabe, T., Sasaki, S., Nagai, K., Roden, D. M., & Aizawa, Y. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.06.031 · Cited by 349
Increasing Body Mass Index and Obesity in the Incident ESRD Population
Kramer, H. J., Saranathan, A., Luke, A., Durazo-Arvizu, R. A., Guichan, C., Hou, S., & Cooper, R. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111241 · Cited by 347
Chronic kidney disease and cardiovascular disease in the Medicare population
Collins, A. J., Li, S., Gilbertson, D. T., Liu, J., Chen, S.-C., & Herzog, C. A. (2003) · Kidney International · doi:10.1046/j.1523-1755.64.s87.5.x · Cited by 346
Self-citationTerami, N., Ogawa, D., Tachibana, H., Hatanaka, T., Wada, J., Nakatsuka, A., Eguchi, J., Horiguchi, C. S., Nishii, N., Yamada, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100777 · Cited by 341
Testing for chronic kidney disease: a position statement from the National Kidney Foundation
Vassalotti, J. A., Stevens, L. A., & Levey, A. S. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.013 · Cited by 331
Weiner, D. E., Tabatabai, S., Tighiouart, H., Elsayed, E., Bansal, N., Griffith, J., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.05.021 · Cited by 325
Weijmer, M. C., van den Dorpel, M. A., Van de Ven, P. J. G., ter Wee, P. M., van Geelen, J. A. C. A., Groeneveld, J. O., van Jaarsveld, B. C., Koopmans, M. G., le Poole, C. Y., Schrander-Van der Meer, A. M., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100870 · Cited by 302
Chronic kidney disease and bone fracture: A growing concern
Nickolas, T. L., Leonard, M. B., & Shane, E. (2008) · Kidney International · doi:10.1038/ki.2008.264 · Cited by 300
Kidney disease as a risk factor for recurrent cardiovascular disease and mortality
Weiner, D. E., Tighiouart, H., Stark, P. C., Amin, M. G., MacLeod, B., Griffith, J. L., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.04.024 · Cited by 276
Oxidants in Chronic Kidney Disease
Shah, S. V., Baliga, R., Rajapurkar, M., & Fonseca, V. A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050500 · Cited by 276
How to estimate GFR-serum creatinine, serum cystatin C or equations?
Herget-Rosenthal, S., Bökenkamp, A., & Hofmann, W. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.10.014 · Cited by 268
Hsu, C.-Y., Vittinghoff, E., Lin, F., & Shlipak, M. G. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-2-200407200-00007 · Cited by 266
Cardiovascular Disease and Subsequent Kidney Disease
Elsayed, E. F., Tighiouart, H., Griffith, J., Kurth, T., Levey, A. S., Salem, D., Sarnak, M. J., & Weiner, D. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.11.1130 · Cited by 255
Epidemiology of Acute Infections among Patients with Chronic Kidney Disease
Dalrymple, L. S., & Go, A. S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01290308 · Cited by 254
Unlocking the biology of RAGE in diabetic microvascular complications
Manigrasso, M. B., Juranek, J., Ramasamy, R., & Schmidt, A. M. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.08.002 · Cited by 209
Badhwar, R., Kaur, G., Popli, H., Yadav, D., & Buttar, H. S. (2020) · Pathophysiology of Obesity-Induced Health Complications · doi:10.1007/978-3-030-35358-2_19 · Cited by 3
Metadata
- Authors
- Gilbertson, D. T., Liu, J., Xue, J. L., Louis, T. A., Solid, C. A., Ebben, J. P., & Collins, A. J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-12
- Volume
- 16
- Issue
- 12
- Pages
- 3736-3741
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2134891317
- Cited by
- 719
- References
- 20
- FWCI
- 42.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.